Improved detection of recurrent bladder cancer using the bard BTA stat test

Urology

Volumn 50, Issue 3, 1997, Pages 349-353

  Sarosdy, Michael F ^a   Hudson, M'Liss A ^b   Ellis, William J ^b   Soloway, Mark S ^b   White, Ralph DeVere ^b   Sheinfeld, Joel ^b   Jarowenko, Mark V ^b   Schellhammer, Paul F ^b   Schervish, Ed W ^b   Patel, Jay V ^b   Chodak, Gerald W ^b   Lamm, Donald L ^b   Johnson, Robert D ^b   Henderson, Mary ^b   Adams, George ^b   Blumenstein, Brent A ^b   Thoelke, Kent R ^b   Pfalzgraf, Randy D ^b   Murchison, Heather A ^b   Brunelle, Sharon L ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CYSTOSCOPY; CYTOLOGY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; RECURRENT CANCER; RISK ASSESSMENT; URINE VOLUME;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0030821841     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00292-6     Document Type: Article

References (17)

1. Whitmore WF Jr: Bladder cancer: an overview. CA Cancer J Clin 38: 213-223, 1988.
2. Mostofi FK, Davis CJ Jr, and Sesterhenn IA: Pathology of tumors of the urinary tract, in Skinner DG, and Lieskovsky G (Eds): Diagnosis and Management of Genitourinary Cancer. Philadelphia, WB Saunders, 1988, pp 83-113.
3. National Bladder Cancer Collaborative Group A: Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. Cancer Res 37: 2911-2915, 1977.
4. Zein T, Wajsman A, Englander LS, Gamarra M, Lopez C, Huben RP, and Pontes JE: Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 132: 670-671, 1984.
5. Sarosdy MF, deVere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, Jarowenko MV, Adams G, and Blumenstein BA: Results of a multicenter trial using the BTA Test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379-384, 1995.
6. D'Hallewin MA, and Baert L: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475-476, 1996.
7. Leyh H, Mazeman E, Hall RR, and Bennett AH: Results of a European multicenter trial comparing the Bard BTA Test to urine cytology in patients suspected of having bladder cancer. J Urol 155: 492A, 1996.
8. Brunelle S, Kinders R, Murchison H, Pfalzgraf R, and Root R: Rapid detection of bladder tumor antigen in urine with the Bard BTA stat Assay. International Congress of Clinical Chemistry, Wembley, UK, July 1996.
9. Leyh H, Marberger M, Pagano F, Bassi P, Sternberg CN, Pansadoro V, Conort P, Boccon-Gibod L, and Thoelke K: Results of a European multicenter trial comparing the BTA stat Test to urine cytology in patients suspected of having bladder cancer. J Urol 157: 337A, 1997.
10. Kinders R, Jones T, Root R, Murchison H, Bruce C, Williams L, and Hass GM: Human bladder tumor antigen is a member of the RCA (regulators of complement activation) gene family. J Urol 157: 28A, 1997.
11. Kinders R, Root R, Jones T, Bruce CL, and Hass GM: Complement factor H-related proteins are expressed in bladder cancers. Cancer Res 38: 29A, 1997.
12. Austyn JM, and Wood KJ: Principles of Cellular and Molecular Immunology. New York, Oxford University Press, 1993, pp 522-554.
13. American Joint Committee on Cancer: Manual for Staging of Cancer (3rd ed). Philadelphia, Lippincott, 1988, pp 194-224.
14. Mostofi FK: Histological Typing of Urinary Bladder Tumors. International Histological Classification of Tumours, No. 10. Geneva, World Health Organization, 1973.
15. Schork MA, and Williams GW: Number of observations required for the comparison of two correlated proportions. Commun Statistical Simulation Computation 139: 349-358, 1980.
16. Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, Lange PH, Messing E, Pasciak RM, Reservitz GB, et al: Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363-367, 1996.
17. Fradet Y, and Cordon-Cardo C: Critical appraisal of tumor markers in bladder cancer. Semin Urol 11: 145-153, 1993.